B Raf (BRAF) Mouse Monoclonal Antibody [Clone ID: OTI5A9]
CAT#: TA500431
BRAF mouse monoclonal antibody, clone OTI5A9 (formerly 5A9)
Size: 30 ul
Formulation: Carrier Free
View other "OTI5A9" antibodies (2)
Special Offer: Get a 15% discount on this product. Use code: "KO15".
USD 823.00
USD 436.00
Specifications
| Product Data | |
| Clone Name | OTI5A9 |
| Applications | FC, IF, IHC, IP, WB |
| Recommended Dilution | WB 1:1000~2000, IF 1:100, FLOW 1:100 |
| Reactivities | Human, Monkey, Mouse, Rat |
| Host | Mouse |
| Isotype | IgG1 |
| Clonality | Monoclonal |
| Immunogen | Full length human recombinant protein of human BRAF (NP_004324) produced in HEK293T cell. |
| Formulation | PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide. |
| Concentration | 1 mg/ml |
| Purification | Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) |
| Conjugation | Unconjugated |
| Storage | Store at -20°C as received. |
| Stability | Stable for 12 months from date of receipt. |
| Predicted Protein Size | 84.4 kDa |
| Gene Name | B-Raf proto-oncogene, serine/threonine kinase |
| Database Link | |
| Background | This gene encodes a protein belonging to the raf/mil family of serine/threonine protein kinases.This protein plays a role in regulating the MAP kinase/ERKs signaling pathway, which affects cell division, differentiation,and secretion. Mutations in this gene are associated with cardiofaciocutaneous syndrome, a disease characterized by heart defects, mental retardation and a distinctive facial appearance. Mutations in this gene have also been associated with various cancers, including non-Hodgkin lymphoma, colorectal cancer, malignant melanoma, thyroid carcinoma,non-small cell lung carcinoma, and adenocarcinoma of lung. A pseudogene, which is located on chromosome X, has been identified for this gene. |
| Synonyms | B-raf; B-RAF1; BRAF1; NS7; RAFB1 |
| Reference Data | |
| Protein Families | Druggable Genome, Protein Kinase |
| Protein Pathways | Acute myeloid leukemia, Bladder cancer, Chemokine signaling pathway, Chronic myeloid leukemia, Colorectal cancer, Endometrial cancer, ErbB signaling pathway, Focal adhesion, Glioma, Insulin signaling pathway, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanoma, mTOR signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Non-small cell lung cancer, Pancreatic cancer, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Regulation of actin cytoskeleton, Renal cell carcinoma, Thyroid cancer, Vascular smooth muscle contraction |
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
| Antibody Resources |
{0} Product Review(s)
Be the first one to submit a review
Germany
Japan
United Kingdom
China